As reported previously, acute myeloid leukemia patients with lower HDAC1 level had better prognosis and HDAC1 may become a new molecular marker and target for clinical diagnosis, prognosis, and treatment of myeloid leukemia 27. Here, HDAC1 is linked to myeloid leukemia.